|
Advertisements
for a test that detects the presence of the BRCA1 and BRCA2 genes
linked to an increased risk for breast and ovarian cancer will
soon be hitting the airwaves.
The ads, due
to begin in September 2002, will be the first to market a genetic
screening test directly to consumers.
Although the
ads may help raise awareness of the link between genetics and
breast cancer, some physicians fear the ads may lead to an increased
rate of invasive follow-up procedures or even preventive mastectomies.
A spokesman
from Myriad Genetics, makers of the tests, said the ads will target
high-risk women and advise them to seek counseling from their
physicians. Consumers will not be able to order the test directly
for themselves.
Other
sources: American Medical Association
|